Man repeatedly injects himself with semen in attempt to cure chronic back pain

Report in Irish Medical Journal says 'innovative' alternative therapy was concocted without medical advice and is first ever case reported in humans

Alex Matthews-King
Health Correspondent
Thursday 17 January 2019 10:31
Comments
Man repeatedly injects himself with semen in attempt to cure chronic back pain

A man repeatedly injected himself with his own semen during a self-concocted course of “alternative therapy” to cure his chronic back pain, a report from Irish doctors has revealed.

The 33-year-old man presented at Adelaide and Meath Hospital, Dublin, after making his back worse lifting a heavy steel object and doctors identified an abscess and a raised red rash on his arm.

“Upon further interrogation of this alternative therapy, he revealed he had injected one monthly “dose” of semen for 18 consecutive months using a hypodermic needle which had been purchased online,” Dr Lisa Dunne, the report’s lead author, wrote in the Irish Medical Journal.

The report, titled "'Semenly' harmless back pain: an unusual presentation of a subcutaneous abscess", says the patient was started on intravenous antibiotics for an infection as the rash continued to spread down his arm.

X-rays revealed a collection of semen in his forearm muscle, but as his back pain improved during his stay at hospital doctors said he “opted to discharge himself” without having the fluid drained.

After a comprehensive search of the medical literature Dr Dunne and colleagues said this is the first reported human case of semen injection, though there have been cases in rats and rabbits.

A “search of more eclectic internet sites and forums” also found no reports of people attempting the treatment for back pain and the report says he had “devised this ‘cure’ independent of any medical advice”.

Doctors said this case was a cautionary lesson on the dangers of self-administering injections by a layperson.

Support free-thinking journalism and attend Independent events

“The case also demonstrates the risks involved with medical experimentation prior to extensive clinical research in the form of phased trials inclusive of safety and efficacy assessments,” the authors add.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in